Vertex Soars on Cystic Fibrosis Drugs and New Gene Therapy; Amazon Withstands Uncertainty with Cloud and Ad Growth
-
Vertex Pharmaceuticals has a successful cystic fibrosis drug franchise and promising new gene therapy for sickle cell disease that could drive growth.
-
Vertex is developing a non-addictive acute pain drug that has shown promise in trials across multiple pain types.
-
Amazon's core ecommerce business proved resilient despite economic uncertainty, aided by cost cutting.
-
Amazon Web Services cloud division delivers over half of the company's profits.
-
Amazon's advertising business is growing quickly and taking market share in the massive global ad market.